Chairman of the House of Representatives Demands Answers from FDA.

Washington D.C. - In a letter to Bernard Schwetz, Acting Commissioner for Food and Drugs for the FDA, the House of Representatives used its oversight jurisdiction over the Food and Drug Administration (FDA) and asked about the FDA's implementation of the Dietary Supplement Health and Education Act of 1994 (DSHEA). They asked specifically for a response to the question of when the GMP's as described in DSHEA will be implemented. The letter was curt and to the point asking the FDA to address the concerns outlined and respond by January 31, 2002.

The main questions posed to the FDA were:

When will the GMP regulations be published?
How long will the comment period be?
When does the FDA plan to issue the final regulation?
Is this one of the top priorities for the FDA in 2002?

The letter also went on to express displeasure with the timeliness of past responses and threatened a Committee hearing.

"In the past, the FDA has failed to provide timely responses to Committee requests. A late or insufficient response may result in a Committee hearing in the near future to resolve these issues"

What will the FDA response be and will it be on time? One day past the deadline the written response had not been recieved. The House or Representatives staff did indicate that they are expecting a response sometime today.

Link to the full letter(270K PDF)

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.